Charles River Laboratories International Inc. (NYSE: CRL) has announced two significant executive appointments. Glenn G. Coleman is set to join as the new Chief Financial Officer, bringing over 30 years of financial management experience, while Kerry Dailey will take on the newly created role of Chief Legal Officer, leading the global legal and compliance functions. These appointments follow the interim CFO Michael G. Knell, and current General Counsel Matthew L. Daniel’s planned departure.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Charles River names Glenn Coleman as CFO, Kerry Dailey as CLO
Charles River Laboratories International Inc. (NYSE: CRL) has announced two significant executive appointments. Glenn G. Coleman is set to join as the new Chief Financial Officer, bringing over 30 years of financial management experience, while Kerry Dailey will take on the newly created role of Chief Legal Officer, leading the global legal and compliance functions. These appointments follow the interim CFO Michael G. Knell, and current General Counsel Matthew L. Daniel’s planned departure.